Skip to content
lifestyle.tweeternet.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Resolve Therapeutics, LLC
Resolve Therapeutics Completes Enrollment in Phase 2 Study of RSLV-132 in Sjögren’s Disease
October 7, 2026